Meeting preview
ACAAI 2026: Building bridges for the future in Phoenix
An introduction to the 2026 Annual Scientific Meeting and the clinical conversations it brings together.
The meeting at a glance
The American College of Allergy, Asthma & Immunology’s 2026 Annual Scientific Meeting will take place November 12–16 in Phoenix, Arizona, under the theme “Building Bridges for the Future.” This year’s program spans emerging research and practical advances across allergy and immunology, including precision allergy care, biologics, immunotherapy, emerging targeted therapies, and evolving approaches to urticaria.
An editorial starting point
For Conference Insider, chronic spontaneous urticaria (CSU) will be an important clinical focus. Coverage will examine evolving understanding of the disease, persistent symptom burden, treatment response, and the questions clinicians face when patients remain symptomatic despite existing approaches. With ACAAI 2026 featuring dedicated discussion of advances in spontaneous and inducible urticaria, our reporting will look beyond individual findings to consider how emerging evidence may influence disease management and future treatment strategies.
Preparing for coverage
ACAAI 2026 includes scientific presentations, oral and poster sessions, late-breaking research, and educational programming across allergy and immunology. Conference Insider will distinguish preliminary findings from established evidence while highlighting research with particular relevance to CSU, urticaria treatment, disease mechanisms, targeted therapies, symptom control, and clinical decision-making. Readers planning to attend should use the official ACAAI program for session details and scheduling updates, as programming remains subject to change.
Source: ACAAI — 2026 meeting information.